Table 1 Baseline characteristics of patients
Cabergoline group (n = 118) | Antagonist rescue combined with cabergoline group (n = 118) | P value | |
|---|---|---|---|
Age (years) | 27.35 ± 5.98 | 26.69 ± 5.58 | 0.387 |
Body mass index (Kg/m2) | 25.85 ± 4.54 | 26.47 ± 4.23 | 0.28 |
Duration of infertility (years) | 5.76 ± 2.65 | 6.14 ± 2.58 | 0.275 |
Type of infertility | |||
• Primary | 102/118(86.44 %) | 97/118(82.2 %) | 0.371 |
• Secondary | 16/118(13.56 %) | 21/118(17.8 %) | 0.371 |
Basal FSH (IU/L) | 6.29 ± 1.53 | 6.31 ± 1.48 | 0.897 |
Antral follicle count | 21.46 ± 4.17 | 22.05 ± 3.75 | 0.252 |
Patients with amenorrhea or oligomenorrhea | 12/118(10.17 %) | 14/118(11.86 %) | 0.678 |
Cause of infertility | |||
• Tubal Factor | 31/118(26.27 %) | 40/118(33.9 %) | 0.202 |
• PCOS | 32/118(27.12 %) | 29/118(24.58 %) | 0.656 |
• Unexplained | 17/118(14.41 %) | 12/118(10.17 %) | 0.322 |
• Male Factor | 20/118(16.95 %) | 22/118(18.64 %) | 0.734 |
• Two or more factors | 18/118(15.25 %) | 15/118(12.71 %) | 0.573 |